FDA updates cybersecurity guidance for medical device makers
The Food and Drug Administration Sept. 26 finalized guidance updating the cybersecurity information device makers should submit to its Center for Devices and Radiological Health or Center for Biologics Evaluation and Research for premarket review of devices that have cybersecurity considerations. The recommendations are intended to help manufacturers meet their obligations under section 524B of the Federal Food, Drug, and Cosmetic Act, enacted in December 2022 as part of the Consolidated Appropriations Act of 2023, which defines “cyber device” as one that includes a device or software that can connect to the internet and be vulnerable to cybersecurity threats.
Related News Articles
Headline
In his latest AHA Cyber and Risk Intel blog, Scott Gee, AHA deputy national advisor for cybersecurity and risk, explains how hospitals can prepare for and…
AHA Cyber Intel
In today’s heightened threat environment, driven by domestic and geopolitical issues, it is more critical than ever for hospitals to prepare for and mitigate…
Headline
In a statement submitted to the Senate Health, Education, Labor and Pensions Committee for a hearing today on health care cybersecurity and patient privacy,…
Headline
Cyberattacks on hospitals are urgent threats to patient safety, care delivery and public trust. In this conversation, Ajay Gupta, board chair of Trinity Health…
Headline
The Food and Drug Administration yesterday released a safety notice announcing a software patch is available to address cybersecurity vulnerabilities in…
Headline
The Cybersecurity and Infrastructure Security Agency, FBI, Department of Defense Cyber Crime Center and the National Security Agency June 30 released a fact…